[1]
Tyagi, N., Kumar, N., Mehan, S., Singh, A. and Kumar, S. 2024. IN-SILICO EVALUATION OF ROSIGLITAZONE PRODRUG AGAINST NEURODEGENERATIVE DISEASE. Journal of Applied Pharmaceutical Sciences and Research. 7, 3 (Oct. 2024), 42-47. DOI:https://doi.org/10.31069/japsr.v7i3.06.